Ticker > Company >

JHS Svendgaard share price

JHS Svendgaard Laboratories Ltd.

NSE: JHS BSE: 532771 SECTOR: Household & Personal Products  40.45 K   53   3

11.70
+0.18 (1.56%)
BSE: 12 Sep 04:01 PM

Price Summary

Today's High

₹ 12.89

Today's Low

₹ 10.82

52 Week High

₹ 32.9

52 Week Low

₹ 9.9

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

100.16 Cr.

Enterprise Value

85.78 Cr.

No. of Shares

8.56 Cr.

P/E

0

P/B

0.58

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20.05

CASH

19.52 Cr.

DEBT

5.14 Cr.

Promoter Holding

34.56 %

EPS (TTM)

₹  -2.11

Sales Growth

29.94%

ROE

-11.58 %

ROCE

-6.78%

Profit Growth

-387.3 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of JHS Svendgaard Laboratories Ltd.

Dr. Gold

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year29.94%
3 Year4.81%
5 Year-7.1%

Profit Growth

1 Year-387.3%
3 Year-282.56%
5 Year-261.98%

ROE%

1 Year-11.58%
3 Year-7.85%
5 Year-4.67%

ROCE %

1 Year-6.78%
3 Year-6.92%
5 Year-3.51%

Debt/Equity

0.0302

Price to Cash Flow

-20.18

Interest Cover Ratio

-21.1269

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 34.56 0.00
Mar 2025 34.56 0.00
Dec 2024 34.56 0.00
Sep 2024 34.56 0.00
Jun 2024 37.73 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -43.517 days.
  • Company has a healthy liquidity position with current ratio of 2.1779.

 Limitations

  • The company has shown a poor profit growth of -282.555291365864% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.80899116549514% for the Past 3 years.
  • Company has a poor ROE of -7.85493333333333% over the past 3 years.
  • Company has a poor ROCE of -6.9215% over the past 3 years
  • Company has negative cash flow from operations of -4.9631.
  • Tax rate is low at -57.8865.
  • The company has a low EBITDA margin of -2.47354% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 24.48 19.68 22.66 25.17 23.45
Total Expenditure 22.51 20.53 22.41 30.55 21.79
Operating Profit 1.97 -0.85 0.25 -5.38 1.66
Other Income 0.32 0.86 0.27 1.42 1
Interest 0.12 0.11 0.13 0.21 0.16
Depreciation 1.97 1.98 1.98 2.02 1.88
Exceptional Items 0 0 0 -2.86 0
Profit Before Tax 0.2 -2.07 -1.58 -9.05 0.63
Tax 0.83 8.25 0.25 -2.09 -0.43
Profit After Tax -0.63 -10.32 -1.84 -6.96 1.06
Adjusted EPS (Rs) -0.08 -1.21 -0.21 -0.81 0.12

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 96.96 79.91 84.81 70.8 92
Total Expenditure 93.3 79.73 93.89 71.73 96
Operating Profit 3.67 0.18 -9.07 -0.93 -4
Other Income 5.55 8.14 11.32 4.31 2.88
Interest 0.45 0.5 0.55 0.46 0.57
Depreciation 5.56 5.9 6.02 6.35 7.95
Exceptional Items 0 0 -18.63 0 -2.86
Profit Before Tax 3.2 1.92 -22.95 -3.42 -12.5
Tax 0.43 4.37 -5.43 0.63 7.24
Net Profit 2.77 -2.44 -17.52 -4.05 -19.74
Adjusted EPS (Rs.) 0.43 -0.38 -2.23 -0.52 -2.31

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 64.4 64.9 78.4 78.4 85.6
Total Reserves 127.08 124.87 95.84 91.89 87.53
Borrowings 0.33 0.37 0.24 0.12 0.69
Other N/C liabilities -2.68 1.86 -6.78 -6.81 -0.26
Current liabilities 19.76 16.6 36.49 23.33 24.7
Total Liabilities 208.9 208.59 204.19 186.93 198.27
Assets
Net Block 58.69 55.41 65.07 90.41 90.33
Capital WIP 8.85 15.83 8.57 0.82 0
Intangible WIP 0 0 0 0 0
Investments 14.21 15.39 2.98 3.46 3.65
Loans & Advances 25.36 35.29 41.33 48.26 47.64
Other N/C Assets 0.32 1.96 1.35 0.55 2.85
Current Assets 101.47 84.72 84.89 43.42 53.8
Total Assets 208.9 208.59 204.19 186.93 198.27
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 3.2 1.92 -22.95 -3.42 -12.5
Adjustment 5.28 -1.33 22.59 5.73 11.87
Changes in Assets & Liabilities 7.72 -11.56 23.62 -11.13 -4.05
Tax Paid -0.77 -0.31 0 0.13 -0.28
Operating Cash Flow 15.42 -11.28 23.25 -8.7 -4.96
Investing Cash Flow -5.58 -0.96 9.68 -21.83 -20.25
Financing Cash Flow 6.42 0.02 -0.9 2.17 23.07
Net Cash Flow 16.26 -12.22 32.03 -28.35 -2.14

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 37.73 34.56 34.56 34.56 34.56
late harish chander nanda... - - - - 0.02
nikhil nanda 33.79 30.95 30.95 30.95 30.95
sushma nanda 3.91 3.58 3.58 3.58 3.58
harish chander nanda 0.03 0.02 0.02 0.02 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 62.27 65.44 65.44 65.44 65.44
aegis investment fund pcc... - 1.67 1.57 1.57 1.57
bhim sain bassi - - - - 1.43
investor education and pr... 0.05 - 0.05 0.05 0.05
llp - 0.35 0.36 0.31 0.35
m.b. finmart private limi... - - 2.10 2.10 2.10
milky investment and trad... - - 2.10 2.10 2.10
puran associates private ... - - 2.10 2.10 2.10
vic enterprises private l... - - 2.10 2.10 2.10
vijay mohan govila 3.05 2.80 2.80 2.80 2.80
investor education and pr... - 0.05 - - -
aspire emerging fund 1.91 - - - -
parker multi commodities 2.05 - - - -
sixth sense india opportu... 6.05 - - - -
zaveri finstock pvt. ltd.... 1.32 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY23
Concall Q2FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY22
Presentation Q3FY22
Presentation Q1FY22

Company News

JHS Svendgaard Laboratories informs about board meeting 18 Aug, 5:07 PM JHS Svendgaard - Quaterly Results 12 Aug, 7:28 PM JHS Svendgaard - Quaterly Results 12 Aug, 7:28 PM JHS Svendgaard Laboratories informs about press release 29 May, 1:35 PM JHS Svendgaard - Quaterly Results 27 May, 7:19 PM JHS Svendgaard - Quaterly Results 27 May, 7:19 PM JHS Svendgaard Laboratories informs about newspaper advertisement 24 May, 4:11 PM JHS Svendgaard Laboratories gets nod for investment in JHS Svendgaard Retail Ventures 5 Mar, 5:14 PM JHS Svendgaard Laboratories informs about outcome of board meeting 5 Mar, 3:14 PM JHS Svendgaard - Quaterly Results 11 Feb, 6:57 PM JHS Svendgaard - Quaterly Results 11 Feb, 6:57 PM Jhs Svendgaard Laboratories informs about registration of sale deeds in J&K 19 Sep, 2:55 PM Jhs Svendgaard Laboratories informs about press release 19 Aug, 1:44 PM JHS Svendgaard Laboratories informs about outcome of board meeting 17 Aug, 10:35 AM JHS Svendgaard - Quaterly Results 12 Aug, 3:25 PM JHS Svendgaard - Quaterly Results 12 Aug, 3:25 PM JHS Svendgaard - Quaterly Results 12 Aug, 3:25 PM JHS Svendgaard Laboratories informs about appointment of statutory auditors 15 Jun, 3:22 PM JHS Svendgaard Laboratories gets nod to acquire 100% stake in JHS Svendgaard Mechanical Warehouse 20 May, 5:11 PM Jhs Svendgaard Laboratories informs about outcome of board meeting 18 May, 3:44 PM JHS Svendgaard - Quaterly Results 18 May, 3:22 PM JHS Svendgaard - Quaterly Results 18 May, 3:22 PM JHS Svendgaard - Quaterly Results 18 May, 3:22 PM JHS Svendgaard Laboratories informs about compliance certificate 22 Apr, 12:09 PM Jhs Svendgaard Laboratories informs about scheme of arrangement 5 Mar, 2:54 PM JHS Svendgaard Laboratories informs about disclosure 17 Feb, 3:15 PM JHS Svendgaard - Quaterly Results 14 Feb, 5:48 PM JHS Svendgaard - Quaterly Results 14 Feb, 5:48 PM JHS Svendgaard Laboratories informs about disclosure 31 Jan, 12:35 PM Jhs Svendgaard Laboratories informs about compliance certificate 11 Jan, 3:51 PM JHS Svendgaard Laboratories informs about AGM and integrated annual report 6 Sep, 10:00 AM JHS Svendgaard Laboratories submits newspaper advertisements 16 Aug, 5:15 PM JHS Svendgaard Laboratories informs about board meeting 24 May, 12:12 PM JHS Svendgaard Laboratories informs about closure of trading window 30 Dec, 5:16 PM Jhs Svendgaard Laboratories informs about scheme of arrangement 21 Dec, 4:32 PM JHS Svendgaard Laboratories informs about disclosure of related party transactions 26 Nov, 10:45 AM JHS Svendgaard - Quaterly Results 10 Nov, 4:02 PM JHS Svendgaard - Quaterly Results 10 Nov, 4:02 PM JHS Svendgaard Laboratories informs about compliances certificate 18 Oct, 4:03 PM JHS Svendgaard Laboratories informs about outcome of board meeting 10 Aug, 4:59 PM JHS Svendgaard - Quaterly Results 9 Aug, 6:15 PM JHS Svendgaard - Quaterly Results 9 Aug, 6:15 PM JHS Svendgaard Laboratories enters into exclusive tie up with Artsana Group 3 Aug, 4:50 PM JHS Svendgaard Laboratories informs about compliances-certificate 14 Jul, 3:56 PM JHS Svendgaard Laboratories informs about transcript of earnings call 7 Jun, 4:54 PM JHS Svendgaard Laboratories informs about resignation of CS cum CO 28 May, 3:56 PM JHS Svendgaard - Quaterly Results 27 May, 3:29 PM JHS Svendgaard - Quaterly Results 8 Feb, 4:31 PM JHS Svendgaard - Quaterly Results 8 Feb, 4:31 PM JHS Svendgaard - Quaterly Results 8 Feb, 4:31 PM

JHS Svendgaard Stock Price Analysis and Quick Research Report. Is JHS Svendgaard an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse JHS Svendgaard. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). JHS Svendgaard has a PE ratio of -5.4570453252418 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. JHS Svendgaard has ROA of -10.2486% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. JHS Svendgaard has a Current ratio of 2.1779.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. JHS Svendgaard has a ROE of -11.5823%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. JHS Svendgaard has a Debt to Equity ratio of 0.0302 which means that the company has low proportion of debt in its capital.

  • Sales growth: JHS Svendgaard has reported revenue growth of 29.943% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of JHS Svendgaard for the current financial year is -4.35251904131969%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for JHS Svendgaard is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of JHS Svendgaard is Rs -2.1092. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of JHS Svendgaard in Ticker for free. Also, one can get the intrinsic value of JHS Svendgaard by using Valuation Calculators, which are available with a Finology ONE subscription. 

JHS Svendgaard FAQs

Q1. What is JHS Svendgaard share price today?
Ans: The current share price of JHS Svendgaard is Rs 11.51.

Q2. What is the market capitalisation of JHS Svendgaard?
Ans: JHS Svendgaard has a market capitalisation of Rs 98.530164866 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of JHS Svendgaard?
Ans: The PE ratio of JHS Svendgaard is -5.4570453252418 and the P/B ratio of JHS Svendgaard is 0.574150745747493, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of JHS Svendgaard share?
Ans: The 52-week high share price of JHS Svendgaard is Rs 32.69, and the 52-week low share price of JHS Svendgaard is Rs 10.02.

Q5. Does JHS Svendgaard pay dividends?
Ans: Currently, JHS Svendgaard does not pay dividends. Dividend yield of JHS Svendgaard is around 0%.

Q6. What are the face value and book value of JHS Svendgaard shares?
Ans: The face value of JHS Svendgaard shares is Rs 10, while the book value per share of JHS Svendgaard is around Rs 20.047. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of JHS Svendgaard?
Ans: JHS Svendgaard has a total debt of Rs 5.1427 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of JHS Svendgaard?
Ans: The ROE of JHS Svendgaard is -11.5823% and ROCE of JHS Svendgaard is -6.7815%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is JHS Svendgaard a good buy for the long term?
Ans: The JHS Svendgaard long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is JHS Svendgaard undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the JHS Svendgaard appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check JHS Svendgaard’s financials?
Ans: You can review JHS Svendgaard’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about JHS Svendgaard
X